PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,699 | -27.6% | 29,672 | 0.0% | 0.07% | -26.0% |
| Q2 2023 | $424,903 | +100.6% | 29,672 | 0.0% | 0.10% | +81.1% |
| Q1 2023 | $211,858 | -36.4% | 29,672 | 0.0% | 0.05% | -41.8% |
| Q4 2022 | $332,920 | +1.2% | 29,672 | 0.0% | 0.09% | -8.1% |
| Q3 2022 | $329,000 | +31.6% | 29,672 | 0.0% | 0.10% | +33.8% |
| Q2 2022 | $250,000 | -39.5% | 29,672 | +130.5% | 0.07% | -30.8% |
| Q3 2021 | $413,000 | -5.3% | 12,872 | 0.0% | 0.11% | -7.8% |
| Q2 2021 | $436,000 | -9.7% | 12,872 | 0.0% | 0.12% | -19.4% |
| Q1 2021 | $483,000 | +12.9% | 12,872 | 0.0% | 0.14% | +1.4% |
| Q4 2020 | $428,000 | – | 12,872 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |